Rebamipide

Specifications

90098-04-7CAS Number

815-380-0EC Number

2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acidIUPAC Name

C19H15ClN2O4Chemical Formula

370.8 g/molMolecular Weight

rebamipide; 90098-04-7; Proamipide; Mucosta; OPC-12759; Rebamipida; Rebator; Rebamipidum; DTXSID8045937; 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid; OPC 12759; NSC-758955; LR583V32ZR; DTXCID6025937; 2-(4-chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid; 2-[(4-chlorophenyl)formamido]-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid; 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid; 2-((4-chlorobenzoyl)amino)-3-(2-oxo-1H-quinolin-4-yl)propanoic acid; 2-((4-chlorophenyl)formamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid; RefChem:878997; A02BX14; alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanoic Acid; (2RS)-2-(4-Chlorobenzoylamino)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid; 815-380-0; 111911-87-6; Pramipide; 139344-42-6; MFCD00866895; 2-(4-Chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)propionic acid; 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid; 2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid; NCGC00095161-01; 2-(4-Chloro-benzoylamino)-3-(2-hydroxy-quinolin-4-yl)-propionic acid; Rebamipide [INN:JAN]; 2-[(4-chlorobenzoyl)amino]-3-(2-hydroxyquinolin-4-yl)propanoic acid; Rebamipidum [INN-Latin]; 4-Quinolinepropanoicacid, a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-; CAS-90098-04-7; CCRIS 3585; SR-05000001520; UNII-LR583V32ZR; N-[(4-chlorophenyl)carbonyl]-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine; Mucosta (TN); REBAMIPIDE [MI]; REBAMIPIDE [INN]; REBAMIPIDE [JAN]; Spectrum2_000039; Spectrum3_001959; Rebamipide (JP17/INN); (+-)-2-(4-Chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid; (+-)-1,2-Dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoic acid; REBAMIPIDE [WHO-DD]; BSPBio_003559; GTPL871; MLS006011883; SCHEMBL221527; SPECTRUM1505310; SPBio_000137; orb1223708; orb1308173; Rebamipide - Bio-X trade mark; CHEMBL1697771; SCHEMBL28009835; CHEBI:93814; KBio3_002880; OPC-759; GLXC-06575; HMS1922B20; HMS2090L13; HMS3655L11; HMS3714A15; HMS5080L17; Pharmakon1600-01505310; 2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid; HY-B0360; Tox21_111460; BBL011328; CCG-39619; EBC-17077; MFCD11114396; NSC758955; s2032; STK577121; STL146407; 2-(4-chlorobenzoylamino)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propionic acid; AKOS005501649; AKOS005721106; Tox21_111460_1; AC-6841; AC-7588; DB11656; FC15908; NSC 758955; 4-Quinolinepropanoic acid, 1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-, (+-)-; NCGC00095161-02; NCGC00095161-03; NCGC00095161-04; NCGC00095161-05; NCGC00095161-14; NCGC00095161-15; BC164330; SMR003309276; SY057250; VS-02924; SBI-0207054.P001; R0085; R1806; SW199113-2; D01121; AB01275518-01; AB01275518_02; AB01275518_03; EN300-19651969; F300998; Q7301602; SR-05000001520-1; SR-05000001520-2; SR-05000001520-3; BRD-A15909516-001-02-5; BRD-A15909516-001-03-3; BRD-A15909516-001-06-6; BRD-A15909516-001-07-4; Z2289798874; 2-(4-chlorobenzoylamino)-3-(2-quinolon-4-yl)propionic acid; 2-(4-chlorobenzoylamino)-3-[2(1h)-quinolinon-4-yl] propionic acid; N-(4-Chlorobenzoyl)-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine; N-[(4-chlorophenyl)carbonyl]-3-(2-hydroxyquinolin-4-yl)alanine; 2-(4-Chlorobenzamido)-3-(2-oxo-1,2-dihydro-4-quinolyl)propanoic Acid; 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoicacid; (+/-)-.ALPHA.-(P-CHLOROBENZAMIDO)-1,2-DIHYDRO-2-OXO-4-QUINOLINEPROPIONIC ACID; (+/-)-2-(4-CHLOROBENZOYLAMINO)-3-(2(1H)-QUINOLINON-4-YL)-PROPIONIC ACID; 4-QUINOLINEPROPANOIC ACID, .ALPHA.-((4-CHLOROBENZOYL)AMINO)-1,2-DIHYDRO-2-OXO-; 4-Quinolinepropanoic acid,a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, (+/-)-; 4-Quinolinepropanoic acid,a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, (A+/-)-; alpha-[(4-Chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid hydrateSynonyms